메뉴 건너뛰기




Volumn 11, Issue 8, 2015, Pages

Parsimonious Determination of the Optimal Infectious Dose of a Pathogen for Nonhuman Primate Models

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOSE CALCULATION; NONHUMAN; OPTIMAL INFECTIOUS DOSE; OUTCOME ASSESSMENT; PATHOGENESIS; PRIMATE MODEL; VIRUS LOAD; ANIMAL; BIOLOGICAL MODEL; DISEASE MODEL; INFECTION; MICROBIOLOGY; PRIMATE;

EID: 84940737670     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1005100     Document Type: Article
Times cited : (12)

References (29)
  • 1
    • 33846588340 scopus 로고    scopus 로고
    • Preclinical assessment of HIV vaccines and microbicides by repeated low-dose virus challenges
    • Regoes RR, Longini IM, Feinberg MB, Staprans SI, (2005) Preclinical assessment of HIV vaccines and microbicides by repeated low-dose virus challenges. PLoS Med 2: e249. 16018721
    • (2005) PLoS Med , vol.2 , pp. 249
    • Regoes, R.R.1    Longini, I.M.2    Feinberg, M.B.3    Staprans, S.I.4
  • 2
    • 70349324443 scopus 로고    scopus 로고
    • Assessing vaccine effects in repeated low-dose challenge experiments
    • Hudgens MG, Gilbert PB, (2009) Assessing vaccine effects in repeated low-dose challenge experiments. Biometrics 65: 1223–1232. doi: 10.1111/j.1541-0420.2009.01189.x 19397589
    • (2009) Biometrics , vol.65 , pp. 1223-1232
    • Hudgens, M.G.1    Gilbert, P.B.2
  • 3
    • 69149087672 scopus 로고    scopus 로고
    • Power to detect the effects of HIV vaccination in repeated low-dose challenge experiments
    • Hudgens MG, Gilbert PB, Mascola JR, Wu CD, Barouch DH, et al. (2009) Power to detect the effects of HIV vaccination in repeated low-dose challenge experiments. J Infect Dis 200: 609–613. doi: 10.1086/600891 19591571
    • (2009) J Infect Dis , vol.200 , pp. 609-613
    • Hudgens, M.G.1    Gilbert, P.B.2    Mascola, J.R.3    Wu, C.D.4    Barouch, D.H.5
  • 4
    • 84861885292 scopus 로고    scopus 로고
    • Macaque studies of vaccine and microbicide combinations for preventing HIV-1 sexual transmission
    • Barouch DH, Klasse PJ, Dufour J, Veazey RS, Moore JP, (2012) Macaque studies of vaccine and microbicide combinations for preventing HIV-1 sexual transmission. Proc Natl Acad Sci U S A 109: 8694–8698. doi: 10.1073/pnas.1203183109 22586094
    • (2012) Proc Natl Acad Sci U S A , vol.109 , pp. 8694-8698
    • Barouch, D.H.1    Klasse, P.J.2    Dufour, J.3    Veazey, R.S.4    Moore, J.P.5
  • 5
    • 33746772048 scopus 로고    scopus 로고
    • HIV-1 DNA/MVA vaccination reduces the per exposure probability of infection during repeated mucosal SHIV challenges
    • Ellenberger D, Otten RA, Li B, Aidoo M, Rodriguez IV, et al. (2006) HIV-1 DNA/MVA vaccination reduces the per exposure probability of infection during repeated mucosal SHIV challenges. Virology 352: 216–225. 16725169
    • (2006) Virology , vol.352 , pp. 216-225
    • Ellenberger, D.1    Otten, R.A.2    Li, B.3    Aidoo, M.4    Rodriguez, I.V.5
  • 6
    • 39849100140 scopus 로고    scopus 로고
    • Prevention of rectal SHIV transmission in macaques by daily or intermittent prophylaxis with emtricitabine and tenofovir
    • Garcia-Lerma JG, Otten RA, Qari SH, Jackson E, Cong ME, et al. (2008) Prevention of rectal SHIV transmission in macaques by daily or intermittent prophylaxis with emtricitabine and tenofovir. PLoS Med 5: e28. doi: 10.1371/journal.pmed.0050028 18254653
    • (2008) PLoS Med , vol.5 , pp. 28
    • Garcia-Lerma, J.G.1    Otten, R.A.2    Qari, S.H.3    Jackson, E.4    Cong, M.E.5
  • 7
    • 61949216736 scopus 로고    scopus 로고
    • Effector memory T cell responses are associated with protection of rhesus monkeys from mucosal simian immunodeficiency virus challenge
    • Hansen SG, Vieville C, Whizin N, Coyne-Johnson L, Siess DC, et al. (2009) Effector memory T cell responses are associated with protection of rhesus monkeys from mucosal simian immunodeficiency virus challenge. Nat Med 15: 293–299. doi: 10.1038/nm.1935 19219024
    • (2009) Nat Med , vol.15 , pp. 293-299
    • Hansen, S.G.1    Vieville, C.2    Whizin, N.3    Coyne-Johnson, L.4    Siess, D.C.5
  • 8
    • 68349160853 scopus 로고    scopus 로고
    • Effective, low-titer antibody protection against low-dose repeated mucosal SHIV challenge in macaques
    • Hessell AJ, Poignard P, Hunter M, Hangartner L, Tehrani DM, et al. (2009) Effective, low-titer antibody protection against low-dose repeated mucosal SHIV challenge in macaques. Nat Med 15: 951–954. doi: 10.1038/nm.1974 19525965
    • (2009) Nat Med , vol.15 , pp. 951-954
    • Hessell, A.J.1    Poignard, P.2    Hunter, M.3    Hangartner, L.4    Tehrani, D.M.5
  • 9
    • 36048991264 scopus 로고    scopus 로고
    • No evidence for consistent virus-specific immunity in simian immunodeficiency virus-exposed, uninfected rhesus monkeys
    • Letvin NL, Rao SS, Dang V, Buzby AP, Korioth-Schmitz B, et al. (2007) No evidence for consistent virus-specific immunity in simian immunodeficiency virus-exposed, uninfected rhesus monkeys. J Virol 81: 12368–12374. 17686853
    • (2007) J Virol , vol.81 , pp. 12368-12374
    • Letvin, N.L.1    Rao, S.S.2    Dang, V.3    Buzby, A.P.4    Korioth-Schmitz, B.5
  • 10
    • 79955680409 scopus 로고    scopus 로고
    • Immune and Genetic Correlates of Vaccine Protection Against Mucosal Infection by SIV in Monkeys
    • Letvin NL, Rao SS, Montefiori DC, Seaman MS, Sun Y, et al. (2011) Immune and Genetic Correlates of Vaccine Protection Against Mucosal Infection by SIV in Monkeys. Sci Transl Med 3: 81ra36. doi: 10.1126/scitranslmed.3002351 21543722
    • (2011) Sci Transl Med , vol.3 , pp. 36-81
    • Letvin, N.L.1    Rao, S.S.2    Montefiori, D.C.3    Seaman, M.S.4    Sun, Y.5
  • 11
    • 10044227530 scopus 로고    scopus 로고
    • A period of transient viremia and occult infection precedes persistent viremia and antiviral immune responses during multiple low-dose intravaginal simian immunodeficiency virus inoculations
    • Ma ZM, Abel K, Rourke T, Wang Y, Miller CJ, (2004) A period of transient viremia and occult infection precedes persistent viremia and antiviral immune responses during multiple low-dose intravaginal simian immunodeficiency virus inoculations. J Virol 78: 14048–14052. 15564513
    • (2004) J Virol , vol.78 , pp. 14048-14052
    • Ma, Z.M.1    Abel, K.2    Rourke, T.3    Wang, Y.4    Miller, C.J.5
  • 12
    • 1542287436 scopus 로고    scopus 로고
    • Repeated low-dose mucosal simian immunodeficiency virus SIVmac239 challenge results in the same viral and immunological kinetics as high-dose challenge: a model for the evaluation of vaccine efficacy in nonhuman primates
    • McDermott AB, Mitchen J, Piaskowski S, De Souza I, Yant LJ, et al. (2004) Repeated low-dose mucosal simian immunodeficiency virus SIVmac239 challenge results in the same viral and immunological kinetics as high-dose challenge: a model for the evaluation of vaccine efficacy in nonhuman primates. J Virol 78: 3140–3144. 14990733
    • (2004) J Virol , vol.78 , pp. 3140-3144
    • McDermott, A.B.1    Mitchen, J.2    Piaskowski, S.3    De Souza, I.4    Yant, L.J.5
  • 13
    • 19944428117 scopus 로고    scopus 로고
    • Multiple vaginal exposures to low doses of R5 simian-human immunodeficiency virus: strategy to study HIV preclinical interventions in nonhuman primates
    • Otten RA, Adams DR, Kim CN, Jackson E, Pullium JK, et al. (2005) Multiple vaginal exposures to low doses of R5 simian-human immunodeficiency virus: strategy to study HIV preclinical interventions in nonhuman primates. J Infect Dis 191: 164–173. 15609225
    • (2005) J Infect Dis , vol.191 , pp. 164-173
    • Otten, R.A.1    Adams, D.R.2    Kim, C.N.3    Jackson, E.4    Pullium, J.K.5
  • 14
    • 77956042087 scopus 로고    scopus 로고
    • Macaques vaccinated with simian immunodeficiency virus SIVmac239Delta nef delay acquisition and control replication after repeated low-dose heterologous SIV challenge
    • Reynolds MR, Weiler AM, Piaskowski SM, Kolar HL, Hessell AJ, et al. (2010) Macaques vaccinated with simian immunodeficiency virus SIVmac239Delta nef delay acquisition and control replication after repeated low-dose heterologous SIV challenge. J Virol 84: 9190–9199. doi: 10.1128/JVI.00041-10 20592091
    • (2010) J Virol , vol.84 , pp. 9190-9199
    • Reynolds, M.R.1    Weiler, A.M.2    Piaskowski, S.M.3    Kolar, H.L.4    Hessell, A.J.5
  • 15
    • 84908516284 scopus 로고    scopus 로고
    • Immunological and virological mechanisms of vaccine-mediated protection against SIV and HIV
    • Roederer M, Keele BF, Schmidt SD, Mason RD, Welles HC, et al. (2013) Immunological and virological mechanisms of vaccine-mediated protection against SIV and HIV. Nature.
    • (2013) Nature
    • Roederer, M.1    Keele, B.F.2    Schmidt, S.D.3    Mason, R.D.4    Welles, H.C.5
  • 16
    • 84874670092 scopus 로고    scopus 로고
    • Protection afforded by an HIV vaccine candidate in macaques depends on the dose of SIVmac251 at challenge exposure
    • Vaccari M, Keele BF, Bosinger SE, Doster MN, Ma ZM, et al. (2013) Protection afforded by an HIV vaccine candidate in macaques depends on the dose of SIVmac251 at challenge exposure. J Virol 87: 3538–3548. doi: 10.1128/JVI.02863-12 23325681
    • (2013) J Virol , vol.87 , pp. 3538-3548
    • Vaccari, M.1    Keele, B.F.2    Bosinger, S.E.3    Doster, M.N.4    Ma, Z.M.5
  • 17
    • 19944433130 scopus 로고    scopus 로고
    • Attenuated poxvirus-based simian immunodeficiency virus (SIV) vaccines given in infancy partially protect infant and juvenile macaques against repeated oral challenge with virulent SIV
    • Van Rompay KK, Abel K, Lawson JR, Singh RP, Schmidt KA, et al. (2005) Attenuated poxvirus-based simian immunodeficiency virus (SIV) vaccines given in infancy partially protect infant and juvenile macaques against repeated oral challenge with virulent SIV. J Acquir Immune Defic Syndr 38: 124–134. 15671796
    • (2005) J Acquir Immune Defic Syndr , vol.38 , pp. 124-134
    • Van Rompay, K.K.1    Abel, K.2    Lawson, J.R.3    Singh, R.P.4    Schmidt, K.A.5
  • 18
    • 33744902339 scopus 로고    scopus 로고
    • Vaccine-induced cellular immune responses reduce plasma viral concentrations after repeated low-dose challenge with pathogenic simian immunodeficiency virus SIVmac239
    • Wilson NA, Reed J, Napoe GS, Piaskowski S, Szymanski A, et al. (2006) Vaccine-induced cellular immune responses reduce plasma viral concentrations after repeated low-dose challenge with pathogenic simian immunodeficiency virus SIVmac239. J Virol 80: 5875–5885. 16731926
    • (2006) J Virol , vol.80 , pp. 5875-5885
    • Wilson, N.A.1    Reed, J.2    Napoe, G.S.3    Piaskowski, S.4    Szymanski, A.5
  • 19
    • 84872028026 scopus 로고    scopus 로고
    • MiniCD4 microbicide prevents HIV infection of human mucosal explants and vaginal transmission of SHIV(162P3) in cynomolgus macaques
    • Dereuddre-Bosquet N, Morellato-Castillo L, Brouwers J, Augustijns P, Bouchemal K, et al. (2012) MiniCD4 microbicide prevents HIV infection of human mucosal explants and vaginal transmission of SHIV(162P3) in cynomolgus macaques. PLoS Pathog 8: e1003071. doi: 10.1371/journal.ppat.1003071 23236282
    • (2012) PLoS Pathog , vol.8 , pp. 1003071
    • Dereuddre-Bosquet, N.1    Morellato-Castillo, L.2    Brouwers, J.3    Augustijns, P.4    Bouchemal, K.5
  • 20
    • 84865986541 scopus 로고    scopus 로고
    • An intravaginal ring that releases the NNRTI MIV-150 reduces SHIV transmission in macaques
    • Singer R, Mawson P, Derby N, Rodriguez A, Kizima L, et al. (2012) An intravaginal ring that releases the NNRTI MIV-150 reduces SHIV transmission in macaques. Sci Transl Med 4: 150ra123. doi: 10.1126/scitranslmed.3003936 22956201
    • (2012) Sci Transl Med , vol.4 , pp. 123-150
    • Singer, R.1    Mawson, P.2    Derby, N.3    Rodriguez, A.4    Kizima, L.5
  • 21
    • 67649848111 scopus 로고    scopus 로고
    • Microbicide safety/efficacy studies in animals: macaques and small animal models
    • Veazey RS, (2008) Microbicide safety/efficacy studies in animals: macaques and small animal models. Curr Opin HIV AIDS 3: 567–573. doi: 10.1097/COH.0b013e32830891bb 19373023
    • (2008) Curr Opin HIV AIDS , vol.3 , pp. 567-573
    • Veazey, R.S.1
  • 22
    • 50949097030 scopus 로고    scopus 로고
    • Prevention of SIV rectal transmission and priming of T cell responses in macaques after local pre-exposure application of tenofovir gel
    • Cranage M, Sharpe S, Herrera C, Cope A, Dennis M, et al. (2008) Prevention of SIV rectal transmission and priming of T cell responses in macaques after local pre-exposure application of tenofovir gel. PLoS Med 5: e157; discussion e157. doi: 10.1371/journal.pmed.0050157 18684007
    • (2008) PLoS Med , vol.5 , pp. 157
    • Cranage, M.1    Sharpe, S.2    Herrera, C.3    Cope, A.4    Dennis, M.5
  • 23
    • 33745158157 scopus 로고
    • A Simple Methodd of Estimating Fifty Per Cent Endpoints
    • Reed LJ, Muench H, (1938) A Simple Methodd of Estimating Fifty Per Cent Endpoints. Amer J of Hygeine 27: 493–407.
    • (1938) Amer J of Hygeine , vol.27 , pp. 407-493
    • Reed, L.J.1    Muench, H.2
  • 24
    • 0026754502 scopus 로고
    • Statistical analysis of sparse infection data and its implications for retroviral treatment trials in primates
    • Spouge JL, (1992) Statistical analysis of sparse infection data and its implications for retroviral treatment trials in primates. Proc Natl Acad Sci U S A 89: 7581–7585. 1323844
    • (1992) Proc Natl Acad Sci U S A , vol.89 , pp. 7581-7585
    • Spouge, J.L.1
  • 26
    • 0029078329 scopus 로고
    • Repeated exposure of rhesus macaques to low doses of simian immunodeficiency virus (SIV) did not protect them against the consequences of a high-dose SIV challenge
    • Dittmer U, Stahl-Hennig C, Coulibaly C, Nisslein T, Luke W, et al. (1995) Repeated exposure of rhesus macaques to low doses of simian immunodeficiency virus (SIV) did not protect them against the consequences of a high-dose SIV challenge. J Gen Virol 76 (Pt 6): 1307–1315. 7782761
    • (1995) J Gen Virol , vol.76 , pp. 1307-1315
    • Dittmer, U.1    Stahl-Hennig, C.2    Coulibaly, C.3    Nisslein, T.4    Luke, W.5
  • 29
    • 84870717488 scopus 로고    scopus 로고
    • The role of exposure history on HIV acquisition: insights from repeated low-dose challenge studies
    • Regoes RR, (2012) The role of exposure history on HIV acquisition: insights from repeated low-dose challenge studies. PLoS Comput Biol 8: e1002767. doi: 10.1371/journal.pcbi.1002767 23180981
    • (2012) PLoS Comput Biol , vol.8 , pp. 1002767
    • Regoes, R.R.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.